McKesson Corporation

MCK | Healthcare | NYSE
$850.18
+8.51 (+1.01%)

Key Metrics

Market Cap
$105.75B
P/E Ratio
34.01
EPS
$25.00
Beta
N/A
Dividend Yield
N/A
ROE
-124.79%
Current Ratio
0.88

Company Information

Industry
Medical Distribution

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally It operates through four segments US Pharmaceutical International MedicalSurgical Solutions and Prescription Technology Solutions RxTS The US Pharmaceutical segment distributes branded generic specialty biosimilar and overthecounter pharmaceutical drugs and other healthcarerelated products This segment also provides practice management technology clinical support and business solutions to communitybased oncology and other specialty practices and consulting outsourcing technological and other services as well as sells financial operational and clinical solutions to pharmacies The International segment offers distribution and services to wholesale institutional and retail customers in 13 European countries and Canada The MedicalSurgical Solutions segment provides medicalsurgical supply distribution logistics and other services to healthcare providers The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys connects pharmacies providers payers and biopharma companies to deliver innovative access and adherence solutions and provides thirdparty logistics and wholesale distribution support solutions McKesson Corporation was founded in 1833 and is headquartered in Irving Texas

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-08-06 $8.26 $8.14 +1.5%
2025-05-08 $10.12 $9.83 +3.0%
2025-02-05 $8.03 $8.60 -6.6%
2024-11-06 $7.07 $6.88 +2.8%

Financial Ratios (TTM)

Gross Margin
3.33%
Operating Margin
1.09%
Net Margin
0.84%
ROA
3.89%
Price to Book
-53.44
Price to Sales
0.28